Fapon Spotlights Localization-Focused One-Stop IVD Solutions at WHX Labs Dubai 2026

A central focus of Fapon’s presence is its Local Manufacturing Solutions, which support localization across chemiluminescence immunoassay (CLIA), clinical biochemistry, lateral flow assay (LFA), and molecular diagnostics platforms. These solutions provide full-chain technology transfer, covering core raw materials, reagent solutions, open-system instruments, R&D expertise, and production processes, enabling partners to establish end-to-end local manufacturing and commercialization capabilities.

Fapon is also highlighting its blood-based Alzheimer’s disease (AD) testing solution, which supplies bulk reagents and raw materials for key biomarkers including p-tau 217, p-tau 181, Aβ40, Aβ42, GFAP, and NfL. These biomarkers exhibit high sensitivity and specificity and correlate strongly with predicate kits and established clinical diagnostic tests, empowering IVD manufacturers worldwide to develop more accurate and reliable AD assays.

In addition, Fapon is demonstrating its chemiluminescence one-stop solution, including the Shine series CLIA analyzers with throughputs ranging from 120 T/h to 900 T/h, more than 70 self-developed reagent solutions, and supporting core raw materials. The company is also showcasing recombinant quality control and calibrator materials, including RF, HbA1c, and HIV/HIV-P24, as well as LAMP-based solutions for rapid molecular diagnostics.

Supported by manufacturing facilities spanning more than 100,000 m² and a global R&D and production network, Fapon supplies partners in over 70 countries and regions and collaborates with more than 2,500 organizations worldwide.